Patellar, Sandra D.

HRN: 28-90-04  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/22/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/22/2026
04/29/2026
IV
33mg
Q24
Neonatal Sepsis Vs N. Pneumonia
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  PneumoniaUnspecified Sepsis    Compliance to guidelines: